Oliver Adam

2.2k total citations
28 papers, 1.7k citations indexed

About

Oliver Adam is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Oliver Adam has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Oliver Adam's work include Atrial Fibrillation Management and Outcomes (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Connective tissue disorders research (3 papers). Oliver Adam is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Connective tissue disorders research (3 papers). Oliver Adam collaborates with scholars based in Germany, United States and Netherlands. Oliver Adam's co-authors include Michael Böhm, Ulrich Laufs, Hans‐Joachim Schäfers, Sven Waßmann, Kerstin Strehlow, Georg Nickenig, Christian Grohé, Daniel Lavall, Mark A. Sussman and Shashi Kumar Gupta and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Oliver Adam

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Adam Germany 17 785 541 282 263 195 28 1.7k
Jérémy Bellien France 23 630 0.8× 388 0.7× 241 0.9× 349 1.3× 210 1.1× 76 1.9k
Julie Favre France 19 355 0.5× 514 1.0× 232 0.8× 372 1.4× 113 0.6× 39 1.4k
Nirmal Parajuli Canada 25 754 1.0× 791 1.5× 352 1.2× 367 1.4× 165 0.8× 44 2.1k
Naifeng Liu China 27 495 0.6× 657 1.2× 325 1.2× 304 1.2× 349 1.8× 83 2.1k
Johannes Jacobi Germany 26 810 1.0× 455 0.8× 426 1.5× 299 1.1× 180 0.9× 52 2.1k
Antigoni Miliou Greece 21 501 0.6× 492 0.9× 257 0.9× 113 0.4× 85 0.4× 70 1.6k
Hisao Wakasaki Japan 16 593 0.8× 740 1.4× 192 0.7× 250 1.0× 94 0.5× 34 1.6k
Miho Kawaguchi Japan 14 1.5k 1.9× 364 0.7× 627 2.2× 345 1.3× 209 1.1× 21 2.4k
Hsin-Bang Leu Taiwan 27 604 0.8× 449 0.8× 283 1.0× 177 0.7× 198 1.0× 54 1.8k
Gila Idelman United States 15 419 0.5× 469 0.9× 297 1.1× 139 0.5× 120 0.6× 22 1.2k

Countries citing papers authored by Oliver Adam

Since Specialization
Citations

This map shows the geographic impact of Oliver Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Adam more than expected).

Fields of papers citing papers by Oliver Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Adam. The network helps show where Oliver Adam may publish in the future.

Co-authorship network of co-authors of Oliver Adam

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Adam. A scholar is included among the top collaborators of Oliver Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Adam. Oliver Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adam, Oliver & Fred Zepp. (2017). Atlas der Entwicklungsdiagnostik.
2.
Adam, Oliver, Christina Zimmer, Nina Hanke, et al.. (2015). Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. Journal of Molecular and Cellular Cardiology. 85. 140–150. 32 indexed citations
3.
Lenski, Matthias, Michael Kohlhaas, Oliver Adam, et al.. (2015). Arrhythmia causes lipid accumulation and reduced glucose uptake. Basic Research in Cardiology. 110(4). 40–40. 56 indexed citations
4.
Adam, Oliver & Ulrich Laufs. (2013). Rac1-Mediated Effects of HMG-CoA Reductase Inhibitors (Statins) in Cardiovascular Disease. Antioxidants and Redox Signaling. 20(8). 1238–1250. 28 indexed citations
5.
Ukena, Christian, Felix Mahfoud, Oliver Adam, et al.. (2013). Comparison of unilateral versus bilateral renal denervation in patients with resistant hypertension. European Heart Journal. 34(suppl 1). 2704–2704.
6.
Adam, Oliver, Thomas Thum, Shashi Kumar Gupta, et al.. (2012). Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Research in Cardiology. 107(5). 278–278. 215 indexed citations
7.
Adam, Oliver, Daniel Lavall, Markus Grube, et al.. (2011). Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation. Journal of Molecular and Cellular Cardiology. 50(4). 678–685. 81 indexed citations
8.
Adam, Oliver, Daniel Lavall, Mathias Hohl, et al.. (2010). Rac1-Induced Connective Tissue Growth Factor Regulates Connexin 43 and N-Cadherin Expression in Atrial Fibrillation. Journal of the American College of Cardiology. 55(5). 469–480. 136 indexed citations
9.
Reil, Jan‐Christian, Mathias Hohl, Martin Oberhofer, et al.. (2010). Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Cardiovascular Research. 87(3). 485–493. 50 indexed citations
10.
Neuberger, Hans‐Ruprecht, Jan‐Christian Reil, Oliver Adam, et al.. (2008). Atrial fibrillation in heart failure: Current treatment of patients with remodeled atria. Current Heart Failure Reports. 5(4). 219–225. 3 indexed citations
11.
Adam, Oliver & Ulrich Laufs. (2008). Antioxidative effects of statins. Archives of Toxicology. 82(12). 885–892. 78 indexed citations
12.
Aicher, Diana, Frank Langer, Oliver Adam, et al.. (2007). Cusp repair in aortic valve reconstruction: Does the technique affect stability?. Journal of Thoracic and Cardiovascular Surgery. 134(6). 1533–1539. 95 indexed citations
13.
Adam, Oliver, Florian Custodis, Mark A. Sussman, et al.. (2007). Role of Rac1 GTPase Activation in Atrial Fibrillation. Journal of the American College of Cardiology. 50(4). 359–367. 143 indexed citations
14.
Kindermann, Michael, Oliver Adam, Nikos Werner, & Michael Böhm. (2007). Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007. Clinical Research in Cardiology. 96(11). 767–786. 33 indexed citations
15.
Schramm, René, Michael D. Menger, Yves Harder, et al.. (2006). Statins inhibit lymphocyte homing to peripheral lymph nodes. Immunology. 120(3). 315–324. 23 indexed citations
16.
Kunihara, Takashi, Diana Aicher, Frank Langer, et al.. (2005). Hypothermic circulatory arrest is not a risk factor for neurologic morbidity in aortic surgery: A propensity score analysis. Journal of Thoracic and Cardiovascular Surgery. 130(3). 712–718. 35 indexed citations
17.
Laufs, Ulrich, Oliver Adam, Kerstin Strehlow, et al.. (2003). Down-regulation of Rac-1 GTPase by Estrogen. Journal of Biological Chemistry. 278(8). 5956–5962. 67 indexed citations
18.
Strehlow, Kerstin, Sven Waßmann, Oliver Adam, et al.. (2003). Modulation of Antioxidant Enzyme Expression and Function by Estrogen. Circulation Research. 93(2). 170–177. 397 indexed citations
19.
Adam, Oliver, et al.. (1994). [Renal side-effects of non-steroidal antirheumatic drugs].. PubMed. 89(6). 305–11. 2 indexed citations
20.
Adam, Oliver & H Wiesinger. (1988). Spontanverläufe der Wegenerschen Granulomatose. Journal of Molecular Medicine. 66(5). 181–186. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérémy Bellien Breakdown of academic impact, for papers by Julie Favre Breakdown of academic impact, for papers by Nirmal Parajuli Breakdown of academic impact, for papers by Naifeng Liu Breakdown of academic impact, for papers by Johannes Jacobi Breakdown of academic impact, for papers by Antigoni Miliou Breakdown of academic impact, for papers by Hisao Wakasaki Breakdown of academic impact, for papers by Miho Kawaguchi Breakdown of academic impact, for papers by Hsin-Bang Leu Breakdown of academic impact, for papers by Gila Idelman
Rankless by CCL
2026